Translational microbiome researchers must look to to decifer leverage cutting edge pre-clinical models in order to identify microbiome-derived targets that can be pursued for therapeutic development. The purpose of this track will be to explore the discovery and pre-clinical assessment of microbiome-based therapeutics across the critical product modalities and disease phenotypes.

Time: 10:15 am
day: Track A - Afternoon - Day One